PMID- 18046045 OWN - NLM STAT- MEDLINE DCOM- 20080303 LR - 20211020 IS - 1460-2377 (Electronic) IS - 0953-8178 (Print) IS - 0953-8178 (Linking) VI - 20 IP - 1 DP - 2008 Jan TI - Massive but selective cytokine dysregulation in the colon of IL-10-/- mice revealed by multiplex analysis. PG - 141-54 AB - IL-10-deficient mice develop enterocolitis due to a failure of cytokine regulation; however, the full scope of that response remains poorly defined. Using multiplex analysis to quantify the activity of 23 regulatory and effector cytokines produced by colonic leukocytes, we demonstrate a vast dysregulation process of 18 cytokines in IL-10-/- mice from 7 to 27 weeks of age. Of those, IL-12p40, IL-6, granulocyte macrophage colony-stimulating factor, IFN-gamma, IL-13 and monocyte chemoattractant protein-1 (MCP-1) had the highest single correlations with pathology (r = 0.7766-0.7016). Importantly, there were strong associations (r = 0.7071-0.9074) between those cytokines and as many as 10 additional cytokines, indicating a high degree of cytokine complexity as disease progressed. IL-17 was notable in that it was produced at high levels by colonic leukocytes from IL-10-/- mice with pathology ranging from mild to severe, though it was not produced by healthy IL-10-/- mice lacking pathology. Tumor necrosis factor alpha (TNFalpha) by itself displayed only a modest association with pathology (r = 0.6340), ranking sixth lowest, though it cross-correlated strongly with the synthesis of 12 other cytokines, implying that the destructive effects associated with TNFalpha may be due to interactions of multiple cytokine activities. IL-23 expression did not correlate with pathology, possibly suggesting that IL-23 is involved in the initiation but not the perpetuation of inflammation. Four cytokines (IL-2, IL-3, IL-4 and IL-5) remained negative in IL-10-/- mice, demonstrating that cytokine dysregulation was not universal. These findings emphasize the need to better understand cytokine networks in chronic inflammation and they provide a rationale for combining immunotherapies in the treatment of intestinal inflammation. FAU - Montufar-Solis, Dina AU - Montufar-Solis D AD - Department of Diagnostic Sciences, Dental Branch, University of Texas Health Science Center at Houston, 6516 MD Anderson Boulevard, Houston, TX, USA. FAU - Schaefer, Jeremy AU - Schaefer J FAU - Hicks, M John AU - Hicks MJ FAU - Klein, John R AU - Klein JR LA - eng GR - R01 DK035566/DK/NIDDK NIH HHS/United States GR - R01 DK035566-22/DK/NIDDK NIH HHS/United States GR - DK035566/DK/NIDDK NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural DEP - 20071128 PL - England TA - Int Immunol JT - International immunology JID - 8916182 RN - 0 (Cytokines) RN - 130068-27-8 (Interleukin-10) SB - IM MH - Animals MH - Colitis/*immunology/pathology/*physiopathology MH - Colon/cytology/immunology/*pathology MH - Cytokines/genetics/immunology/*metabolism MH - Epithelial Cells/cytology/immunology/*pathology MH - Female MH - Interleukin-10/*deficiency/genetics MH - Leukocytes/cytology/immunology/*pathology MH - Male MH - Mice MH - Mice, Inbred BALB C PMC - PMC2756059 MID - NIHMS143711 EDAT- 2007/11/30 09:00 MHDA- 2008/03/04 09:00 PMCR- 2009/10/02 CRDT- 2007/11/30 09:00 PHST- 2007/11/30 09:00 [pubmed] PHST- 2008/03/04 09:00 [medline] PHST- 2007/11/30 09:00 [entrez] PHST- 2009/10/02 00:00 [pmc-release] AID - dxm126 [pii] AID - 10.1093/intimm/dxm126 [doi] PST - ppublish SO - Int Immunol. 2008 Jan;20(1):141-54. doi: 10.1093/intimm/dxm126. Epub 2007 Nov 28.